NCT00268385 2026-03-19
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Sapience Therapeutics
Augusta University
Case Comprehensive Cancer Center
Duke University
Eastern Cooperative Oncology Group